Tag: Albireo

Mergers and Acquisitions

Acquisitive Ipsen builds again with $952m Albireo buy

January 9, 2023

Via: Pharmaphorum

The agreement values Boston-based Albireo at $952 million, with shareholders in the company also in line for another $10-per-share payout in a contingent value right (CVR) if Bylvay (odevixibat) gets approved for a follow-up indication. Albireo secured approval in the […]